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Background:  Attention  deﬁcit  hyperactivity  disorder  (ADHD)  is present  in  about  a quarter  of patients  with
a  substance  use  disorder  (SUD)  and  impulsivity  is a key  feature  of  both  disorders.  However,  very  little  is
known  about  differences  in  impulse  control  and  other  cognitive  functions  between  ADHD  patients  with
and  without  SUD.
Methods:  In  adult  male  medication-naïve  ADHD  patients  with  and  without  comorbid  cocaine  dependence
and  healthy  controls  (matched  on gender,  age  and  IQ), we  measured  motor  impulsivity  (stop  signal  task),
cognitive  impulsivity  (delay  discounting  task),  divided  attention  (trail  making  test),  interference  (Stroop
task),  working  memory  (n-back  task),  and  time  reproduction  (time  reproduction  task).  Additionally,  self-
reported  ADHD  symptoms  (using  the  ADHD  Symptom  Rating  Scale;  ASRS)  and  self-reported  impulsivity
(Barratt  Impulsivity  Scale;  BIS)  were  assessed.
Results: Signiﬁcantly  higher  levels  of  motor  and  cognitive  impulsivity  were  found  in ADHD  patients  with
comorbid  cocaine  dependence  compared  to  ADHD  patients  without  cocaine  dependence  and  controls,
and  both  measures  of  impulsivity  were  highly  correlated.  No  signiﬁcant  group  differences  were  found  on
other  cognitive  measures.  With  regard  to  the  self-report  measures,  only  BIS  attention  subscores  differed
signiﬁcantly  between  ADHD  patients  with  and  without  cocaine  dependence.  ASRS  and  BIS scores  were
not  signiﬁcantly  correlated.
Conclusion: This  is  the  ﬁrst study  showing  that  ADHD  patients  with  cocaine  dependence  are  a  distinctly
more  impulsive  subpopulation  compared  to  ADHD  patients  without  cocaine  dependence  on  objective
measures  of  impulsivity.  These  ﬁndings  are  relevant  to optimize  psycho-education  and  treatment  of
ADHD  patients  with  comorbid  SUD.. Introduction
Attention deﬁcit hyperactivity disorder (ADHD) is a childhood
evelopmental disorder characterized by symptoms of inatten-
ion, hyperactivity and impulsivity. In children with ADHD, a wide
ange of impairments in cognitive functions are found, particularly
egarding executive functions (i.e., response inhibition, working
emory, planning, selective and divided attention, set-shifting, and
ime processing; O’Brien et al., 2010; Pasini et al., 2007; Valko et al.,
010; Willcutt et al., 2005). While ADHD symptoms often wane in
dulthood, these symptoms may  persist in some patients. Studies in
dult ADHD patients reported on deﬁcits in working memory (Finke
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et al., 2011; Marx et al., 2011), reward and emotional processing
(Wilbertz et al., 2012; Marx et al., 2011; Ibán˜ez et al., 2011), time
processing (Valko et al., 2010), and inhibitory control (Bramham
et al., 2012; Cummins et al., 2011; Wilbertz et al., 2012). How-
ever, in adult ADHD patients, measures of impulsivity and selective
attention are reported to improve with age (Bramham et al., 2012).
Adult ADHD is diagnosed in about a quarter of the patients with
substance use dependence (SUD; van Emmerik-van Oortmerssen
et al., 2012). ADHD is, like SUD, characterized by increased levels of
impulsivity. For example, chronic cocaine abusers show increased
motor impulsivity (Fillmore and Rush, 2002) and increased cog-
nitive impulsivity (i.e., impulsive decision making) compared to
non-drug using controls (Coffey et al., 2003; Heil et al., 2006).
Additionally, in SUD, deﬁcits in reward processing, attention, and
Open access under the Elsevier OA license.working memory have been observed (Hester and Garavan, 2004;
van Holst and Schilt, 2011; Verdejo-Garcia et al., 2006), suggesting
a large overlap between ADHD and SUD in cognitive impair-
ments.
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Increased impulsivity, impaired attention, and/or working
emory deﬁcits may  represent common risk factors for the
evelopment of ADHD and SUD, and as a consequence ADHD
atients with increased levels of impulsivity may  be more prone
o develop a SUD later in life. While one of the leading hypothesis
n ADHD research states that ADHD symptoms arise from pri-
ary cognitive/executive impairments (the executive dysfunction
ypothesis), the combination with reward/motivational impair-
ents is believed to play a key role in the pathophysiology of
DHD (dual pathway hypothesis; Sonuga-Barke, 2003; Willcutt
t al., 2005). Various studies have been performed on cognitive
mpairments in (adult) ADHD patients, but no data are currently
vailable on cognitive and/or motivational impairments in ADHD
atients with comorbid SUD. This is unfortunate because cur-
ent ADHD treatments (e.g., methylphenidate) are less effective in
DHD patients with SUD compared to ADHD populations without
UD (Carpentier et al., 2005; Levin et al., 2007), and, subsequently,
reatments in ADHD patients with SUD could be signiﬁcantly
mproved by simultaneously targeting deﬁcits that are speciﬁc for
DHD patients with comorbid SUD.
Here, we investigate a variety of measures of neurocogni-
ive functioning representing both the executive circuit (response
nhibition, set-shifting, working memory, and time reproduc-
ion) and the reward/motivational circuit (delayed discounting)
n non-medicated adult ADHD patients with and without cocaine
ependence, and in non-drug using controls. We  thereby include
istinct measures of impulsivity relating to distinct neurobiolog-
cal circuitries, including motor impulsivity (response inhibition
rising from possible dysfunctions in the executive circuitry)
nd cognitive impulsivity (delayed discounting related to the
eward/motivational circuitry). Additionally, trait impulsivity and
elf-reported ADHD symptoms were assessed, representing dis-
inct subjective measures of impulsive behavior (Broos et al., 2012).
e hypothesize that ADHD patients with and without cocaine
ependence differ from control participants on measures of impuls-
vity, attention, time reproduction, and working memory compared
o control participants. Additionally, we hypothesize that ADHD
atients with comorbid cocaine dependence have increased levels
f (motor and cognitive) impulsivity compared to ADHD patients
ithout cocaine dependence (ADHD) and matched non-drug using
ealthy controls (HC).
. Methods
.1. Subjects
Male adult ADHD patients without cocaine dependence (ADHD; n = 17) and male
dult ADHD patients with cocaine dependence (ADHD + COC; n = 11) were screened
y experienced professionals from various Dutch Addiction and ADHD treatment
enters.  Non-drug using male healthy controls (HC; n = 17) were recruited by local
dvertisement leaﬂets and were matched on gender, age (between 22 and 50 years
ld) and IQ.
In  ADHD and ADHD + COC patients, DSM-IV ADHD was diagnosed using the Con-
ors’ Adult ADHD Diagnostic Interview (CAADID; Conners et al., 1999). The CAADID
ssesses the presence of both adult and childhood ADHD criteria, including the cri-
erion of childhood impairment. If patients did not meet the childhood impairment
riterion  they were excluded from study participation. Thus, all patients that were
ncluded in the study had a DSM-IV diagnosis of adult ADHD diagnosis including the
hildhood impairment. Cocaine dependence was diagnosed in ADHD + COC patients
nd excluded in HC and ADHD patients using the Mini International Neuropsychi-
tric  Interview (MINI; Sheehan et al., 1998). Also using the MINI, other psychiatric
isorders  were excluded in HC patients. Finally, participants were excluded when
aving serious medical illness, or when currently using any drugs other than alcohol,
annabis or nicotine.
The  study was approved by the Academic Medical Center Ethical Committee and
ritten informed consent was given by all participants before testing..2. Clinical assessments
The Dutch version of the National Adult Reading Test (DART; Schmand et al.,
991)  was  used to assess IQ. Nicotine dependency was assessed using the FagerströmDependence 129 (2013) 18– 24 19
test  for Nicotine Dependence (FTND; Heatherton et al., 1991). The Beck Depression
Inventory (BDI; Beck and Steer, 1987) was used to measure symptoms of depression.
2.3.  Cognitive function tasks
Participants were tested individually during a 3 h session. Testing occurred in
a quiet room, in a ﬁxed order. Fixed breaks were provided between tests to avoid
fatigue.  The neuropsychological battery assessed domains of cognitive functioning
that have been found to be impaired in youth and adults with ADHD (Pennington
and  Ozonoff, 1996; Seidman et al., 2004; Tannock et al., 2006; Willcutt et al., 2005).
2.3.1. Motor impulsivity/response inhibition. The stop signal task (Logan et al., 1984)
was used to measure response inhibition. Participants were presented with an arrow
pointed to the right or the left and were required to push a corresponding (left or
right) button on a response box as quickly as possible (go trials). In 25% of the trials,
an auditory stop stimulus was presented several milliseconds following the presen-
tation of the arrow, and participants were instructed to try to inhibit their response
(stop trials). Participants performed 3 blocks of 128 trials each. For each block, a
tracking algorithm was used such that participants inhibited their responses suc-
cessfully in approximately 50% of the stop trials. The primary outcome measure
was  the stop signal reaction time (SSRT; a measure for the speed of inhibition), a
high SSRT reﬂecting low response inhibition, and indicating higher motor impulsi-
vity. Additionally, mean reaction times (MRT; representing psychomotor response
speed) and accuracy of go trials (ACC) were measured.
2.3.2. Cognitive impulsivity/delayed discounting. The delay discounting task was
used to measure impulsive decision making (cognitive impulsivity), by providing
participants  with a choice between an immediate small reward or a larger reward
in  the future (Bickel and Marsch, 2001). Participants were asked to choose between
two hypothetical monetary rewards over a variety of delays in the future: 5 days, 1
and 3 months, and 1, 3 and 10 years. The task consisted of 6 blocks (one per delay),
consisting  of 6–8 trials each, and included an algorithm that assessed the partici-
pant’s  indifference points (Vx; the discounted value of a delayed reward) per delay
using the hyperbolic equation by Mazur (1987). Lower indifference points represent
increased cognitive impulsivity. The primary outcome measure was the discount-
ing  rate k, calculated from the participant’s individual indifference points per delay
(Bickel and Marsch, 2001; Mazur, 1987), where higher k values represent higher
cognitive  impulsivity. In addition, we calculated R2 measures as an indicator of the
ﬁt of the curve to the hyperbolic function.
2.3.3. Interference control. The Stroop color-word task presents congruent stimuli
(i.e., ‘red’ printed in red ink) and incongruent stimuli (i.e., ‘yellowıˇ in red ink) and
measures interference between cognitive processes by requiring the participant to
name the color (‘red’) regardless of the word (‘red’ or ‘green’; Stroop, 1935). Our task
presented stimuli in 4 different colors (red, green, blue and yellow) and included 5
blocks per condition, with 9 trials per block. The primary outcome measure was  the
reaction time during incongruent stimuli (RTI) compared to the reaction times dur-
ing congruent stimuli (RTC), using the equation: (RTI − RTC)/RTC, where higher ratios
represent  decreased interference control. To control for attentional differences, par-
ticipants with mean accuracy under 75% were excluded from data analyses.
2.3.4. Time reproduction. A visual time reproduction paradigm (Rommelse et al.,
2007) was used to assess time reproduction deﬁcits, reﬂecting differences in time
perception. Participants were required to reproduce a visual interval length by
switching on and off a light bulb on a computer screen, including interval lengths
of 1 s, 3 s, 6 s, 12 s and 20 s. The main outcome measures include the relative dis-
crepancy  score (a measure for the relative differences in lengths compared to the
actual length interval, expressed as percentage deviation), where higher discrepancy
scores  indicate greater time reproduction deﬁcits.
2.3.5. Attentional set-shifting. The trail making test was  used to assess attentional
set-shifting  (Spreen and Strauss, 1991). The trail making test parts A and B were
administered  and the set-shifting score was calculated following Stuss et al. (2001)
with the equation (log(Timing B − Timing A)/Timing A). High set-shifting scores are
a measure for deﬁcits in attentional set-shifting.
2.3.6. Working memory. The n-back task (Kirchner, 1958) is a continuous working
memory  task that requires subjects to indicate whether the current letter matches
the  one from n (usually 1–3) steps earlier. We used an in-house version of the task
visualizing a worm and an apple with 4 holes from which the worm could occur. The
task included 2 blocks of 20 trials per n-back condition (0-, 1-, and 2-back) and par-
ticipants had to point out the location from where the worm appeared immediately,
1,  or 2 steps earlier. The primary outcome measure was accuracy per condition, with
more mistakes showing more important working memory deﬁcits.2.4.  Self-report questionnaires
The  Barratt Impulsivity Scale (BIS-11; Patton et al., 1995) is a self-report ques-
tionnaire  and was used to assess (9 aspects of) subjective impulsivity. The ADHD
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Fig. 1. The ﬁtted hyperbolic discounting curves for the mean indifference points
between  large delayed and small immediate hypothetical monetary rewards, for0 C.L. Crunelle et al. / Drug and Al
ymptom Rating Scale (ASRS; Kooij et al., 2005) was  used as a severity indicator of
elf-reported (current) ADHD symptoms in adulthood.
.5.  Statistics
All dependent variables (cognitive tasks and self-report questionnaires) were
hecked  for normality of their distribution using Shapiro–Wilk normality tests.
n  normally distributed data, one-way ANOVAs were performed to assess group
ifferences  related to task performance and self-report questionnaire scores, fol-
owed by post hoc Bonferroni testing when the ANOVA revealed a signiﬁcant group
ffect. When variables were not normally distributed, a logarithmic transformation
as  used for further analysis, or a non-parametric Kruskal–Wallis test was used to
dentify statistical differences between variables of independent samples that were
ot transformed (e.g., performance accuracy data). Correlations are described using
earson’s correlation coefﬁcients. A signiﬁcance level of 0.05 was used as statisti-
ally  signiﬁcant for all statistical tests and all data are presented as means ± standard
eviation.
. Results
.1. Clinical characteristics
All  clinical characteristics were normally distributed
Shapiro–Wilk tests P > 0.05) and means and standard deviations
re presented in Table 1. Groups (HC, ADHD and ADHD + COC) did
ot differ signiﬁcantly in age or IQ. Regarding ADHD subtypes,
he ADHD group mainly consisted of combined and inattentive
ubtypes (100%), while the ADHD + COC group included mainly
yperactive and combined subtypes (91%).
ADHD + COC and HC groups contained more smokers
ADHD + COC 64%; HC 59%) than the ADHD group (41%) but
his difference was not statistically signiﬁcant. Also, the amount
f cigarettes smoked did not differ between groups (P = 0.052),
ut ADHD + COC had statistically signiﬁcantly higher FTND scores,
ndicating more severe nicotine dependence compared to both
DHD and HC groups (P = 0.001). Current use of substances other
han cocaine (alcohol, cannabis, amphetamine, and heroin) did not
iffer between groups.
.2.  Cognitive function tasks
Table  2 shows the outcome measures for the neurocognitive
asks, including the ANOVA level of signiﬁcance and the post hoc
onferroni levels of signiﬁcance.
.2.1.  Motor impulsivity. SSRT and MRT  data were normally dis-
ributed in all groups (Shapiro–Wilk (SSRT): P > 0.14, MRT  P > 0.15).
owever, ACC data were negatively skewed due to the generally
igh performance score and were analyzed using a non-parametric
ruskal–Wallis test.
Table  2 shows that SSRTs were signiﬁcantly higher in the
DHD + COC group compared to the ADHD and HC groups
P < 0.001) and no signiﬁcant differences between ADHD and HCs
ere found on SSRT (P = 0.39). In addition, no group differences
ere found on MRT  measures and on ACC during go trials.
.2.2.  Cognitive impulsivity. Group discounting rates (k) were not
ormally distributed and therefore transformed using a logarithmic
ransformation, which resulted in normal distributions in all groups
Shapiro–Wilk PHC = 0.16; PADHD = 0.78; PADHD + COC = 0.07).
Fig. 1 represents the ﬁtted hyperbolic discounting curves on
he mean indifference points per group. Table 2 shows that the
iscounting rate k signiﬁcantly differed between groups with,
ost hoc, signiﬁcantly higher k values for ADHD + COC compared
o ADHD and compared to HC. No differences in k values were
bserved between ADHD and HC (P = 1.000). Additionally, R2 meas-
res are close to 1, indicating a very good ﬁt to the hyperbolic
iscounting curve (see Fig. 1).control subjects (HC), and ADHD patients without cocaine dependence (ADHD) and
ADHD patients with cocaine dependence (ADHD + COC). R2 represents the ﬁt of the
curve to the hyperbolic function.
3.2.3. Interference control. Data from HCs are not presented due to
inadequate sample size (data from 10 HC participants are missing).
In addition, data from 2 ADHD and 1 ADHD + COC  patients is miss-
ing due to computer failure. Therefore, we  here present data on 15
ADHD and 10 ADHD + COC patients, and do not compare these to
HC data. The main outcome measure, reaction time ratio, was  dis-
tributed normally and no statistically signiﬁcant group differences
were found between ADHD and ADHD + COC on reaction time ratios
and accuracy (see Table 2).
3.2.4. Time reproduction. For each separate time length interval,
relative discrepancy scores were normally distributed and did
not statistically differ between HC, ADHD, and ADHD + COC (see
Table 2).
3.2.5.  Attentional set-shifting. Data from 5 participants (4 HC and
1 ADHD) were missing due to test acquisition failures, and there-
fore data are presented for 13 HCs, 16 ADHD and 11 ADHD + COC
patients. Data were normally distributed and no signiﬁcant group
differences in set shifting scores were found (see Table 2).
3.2.6.  Working memory. Data were missing from 1 ADHD and 1
ADHD + COC participant due to computer failure. Accuracy data
were not normally distributed and therefore analyzed using a
non-parametric Kruskal–Wallis test over groups. No statistical sig-
niﬁcant differences were found in accuracy between groups, for the
1-back condition or for the 2-back condition (see Table 2).
3.3.  Self-report questionnaires
All  self-report questionnaire scores were normally distributed
as indicated by Shapiro–Wilk P-values > 0.05.
3.3.1. Impulsivity. ADHD participants scored signiﬁcantly higher
than HCs on 7 out of 9 subscales of the BIS (Table 2), but there
were no signiﬁcant differences between HC and ADHD on the BIS
subscales motor impulsivity (P = 0.11) and cognitive complexibility
(P = 0.52). Compared to HCs, ADHD + COC patients scored signiﬁ-
cantly higher on all subscales of the BIS (see Table 2). ADHD and
ADHD + COC patients only differed on the BIS subscale attention
(Table 2).3.3.2.  ADHD symptoms. ADHD and ADHD + COC patients scored
signiﬁcantly higher on the ASRS than HCs, but there was no signif-
icant difference on the ASRS between the ADHD and ADHD + COC
groups (see Table 2).
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Table 1
Clinical characteristics of control participants (HC), ADHD patients without cocaine dependence (ADHD) and ADHD patients with cocaine dependence (ADHD + COC).
Abbreviations: DART, Dutch adult reading test. All data are represented as means ± standard deviation. A signiﬁcance level of 0.05 (*) was used as statistically signiﬁcant.
HC ADHD ADHD  + COC
n  = 17 n = 17 n = 11
Age (years) 31 ± 6 33 ± 7 36 ± 6
DART  (IQ) 106  ± 4 105 ± 4 103 ± 6
ADHD  subtype in adulthood
Hyperactive  N (%) – 0/17 (0%) 2/11 (18%)
Inattentive  N (%) – 8/17 (47%) 1/11 (9%)
Combined  N (%) – 9/17 (53%) 8/11 (73%)
Nicotine  use (amount of smokers N (%)) 10/17 (59%) 7/17 (41%) 7/11 (64%)
Cigarettes  per day for smokers 12 ± 6 8 ± 3 15 ± 6
FTND  score for smokers* 3.9 ± 2.0 3.3 ± 1.0 6.9 ± 1.6*
Alcohol use (units per week) 3.2 ± 5.0 7.2 ± 5.3 3.7 ± 4.8
Cannabis  use (grams per week) 0.3 ± 0.6 0.0 ± 0.1 0.6 ± 1.2
Amphetamine use (pills per month) 0 0 0
Heroin  use (grams per week) 0 0 0
Cocaine  use
Years  of cocaine use (mean, SD) – – 12.3 ± 6.0
3
i
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HDays  since last cocaine use (mean, SD) –
Number  of relapses (mean, SD) – 
.4. Correlation analyses
In  none of the groups (ADHD, ADHD + COC, and HC), motor
mpulsivity (SSRT) and cognitive impulsivity (discounting rate k)
ere correlated signiﬁcantly with any of the self-reported BIS
ubscales (all r < 0.51; all P > 0.09). Similarly, motor and cogni-
ive impulsivity measures did not correlate with self-reported
DHD symptoms (ASRS scores) (all r < 0.44; all P > 0.07). However,
n the total sample, signiﬁcant correlations between impulsivity
able 2
rimary outcome measures for neurocognitive tasks and self-reported questionnaires i
nd ADHD patients with cocaine dependence (ADHD + COC). Statistical signiﬁcance of t
ransformation (indicated by T) or on Kruskal–Wallis testing (indicated by KW). Even w
resented in this table for better correspondence with the current literature. We  further
IS: Barratt Impulsivity Scale; ASRS, ADHD Self-Report Scale; NS, not signiﬁcant; * post ho
C  and ADHD + COC groups; pˆost  hoc test difference between ADHD and ADHD + COC gro
HC ADHD 
Motor impulsivity (stop signal task)
Stop signal reaction time (ms) 127.4 ± 20.6 146.2 ± 29.4 
Mean reaction time (ms) 501.3 ± 134.2 522.7 ± 163.2 
Accuracy on go trials (%) 98.9  ± 1.8 97.6 ± 2.7 
Cognitive impulsivity (delay discounting task)
Mean k value 0.0015 ± 0.0016 0.0013 ± 0.0014 
Interference control
Reaction  time (ratio) – 1.12 ± 0.12 
Accuracy (%) – 100 ± 1 
Time reproduction (time reproduction task)
Relative discrepancy score (1 s; %) 26.0 ± 9.3 22.1 ± 6.6 
Relative discrepancy score (3 s; %) 14.0 ± 4.6 13.3 ± 4.8 
Relative discrepancy score (6 s; %) 9.1 ± 4.5 8.3 ± 2.4 
Relative discrepancy score (12 s; %) 7.1 ± 2.7 7.3 ± 3.6 
Relative discrepancy score (20 s; %) 6.1 ± 3.0 6.1 ± 3.6 
Attentional set-shifting (trail making test)
Set shifting score 1.72 ± 0.63 1.77 ± 0.11 
Working memory (n-back task)
Accuracy 1-back (%) 98.8 ± 2.4 99.7 ± 1.1 
Accuracy 2-back (%) 94.8 ± 6.8 93.9 ± 15.1 
Self-reported impulsivity (BIS)
Attention 8.9 ± 2.0 13.1 ± 2.4 
Motor impulsiveness 10.4 ± 1.8 12.4 ± 3.2 
Self-control  13.0 ± 3.0 16.1 ± 2.5 
Cognitive complexibility 6.6 ± 1.5 7.6 ± 2.3 
Perseverance 7.0 ± 1.5 10.6 ± 2.4 
Cognitive instability 3.4 ± 0.9 5.6 ± 1.5 
Attentional impulsiveness 11.9 ± 2.5 17.9 ± 3.2 
Motor  impulsiveness 16.1 ± 2.9 21.4 ± 4.2 
Non-planning impulsiveness 19.6 ± 4.3 23.8 ± 3.9 
Self-reported ADHD symptoms (ASRS score) 2.4 ± 1.9 11.9 ± 3.7 – 677  ± 569
– 1.5 ± 0.9
measures  and BIS subscales and between impulsivity measures and
ASRS scores were found (data not presented), but the correlations
were mainly driven by some high scoring ADHD + COC patients and
some low scoring HC participants, with little to no overlap in scores
between groups. Therefore these correlations should be interpreted
cautiously.Measures of motor and cognitive impulsivity were highly corre-
lated, and ADHD patients (with and without cocaine dependence)
with more severe motor impulsivity also displayed more severe
n control participants (HC), ADHD patients without cocaine dependence (ADHD)
he differences between groups is based on ANOVA, on ANOVA after logarithmic
hen logarithmic transformation was used for analysis, untransformed values are
 indicate the Bonferroni levels of signiﬁcance for the post hoc tests. Abbreviations:
c test difference between HC and ADHD groups; # post hoc test difference between
ups. Data are presented as mean ± standard deviation.
ADHD + COC ANOVA Post hoc Bonferroni
193.2 ± 57.3 P < 0.001 #P < 0.001; ˆP = 0.04
504.9 ± 74.5 NS (P = 0.889) –
98.2 ± 1.3 NS (P = 0.103) (KW) –
0.0138 ± 0.0197 P = 0.001 (T) #P = 0.003; ˆP = 0.002 (T)
1.17 ± 0.10 NS (P = 0.442) –
98 ± 1 NS (P = 0.424) (KW) –
26.2 ± 7.8 NS (P = 0.274) –
12.0 ± 4.9 NS (P = 0.557) –
9.1 ± 3.6 NS (P = 0.760) –
9.1 ± 6.5 NS (P = 0.426) –
7.4 ± 6.2 NS (P = 0.689) –
1.76 ± 0.10 NS (P = 0.334) –
98.6 ± 2.2 NS (P = 0.212) (KW) –
88.0 ± 23.1 NS (P = 0.339) (KW) –
15.5 ± 2.0 P < 0.001 *P < 0.001; #P < 0.001; ˆP = 0.019
13.7 ± 3.0 P = 0.007 #P = 0.007
18.5 ± 2.4 P < 0.001 *P = 0.005; #P < 0.001
8.8 ± 2.1 P = 0.025 #P = 0.021
11.9 ± 1.7 P < 0.001 *P < 0.001; #P < 0.001
5.3 ± 1.3 P < 0.001 *P = 0.001; #P < 0.001
19.1 ± 2.5 P < 0.001 *P < 0.001; #P < 0.001
24.5 ± 3.9 P < 0.001 *P < 0.001; #P < 0.001
27.3 ± 2.5 P < 0.001 *P = 0.01; #P < 0.001
13.4 ± 2.7 P < 0.001 *P < 0.001; #P < 0.001
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mpulsive decision making deﬁcits (ADHD: r = 0.70, P = 0.002;
DHD + COC: r = 0.93, P < 0.001). However, this correlation was  not
bserved in healthy controls (r = 0.11, P = 0.70).
Additionally, no correlations were found between ASRS scores
nd other performance indicators of other neurocognitive tasks,
ncluding interference control, time reproduction, set-shifting
cores and working memory accuracy scores.
Finally, differences in smoking comorbidity may  confound the
elation between the presence of cocaine dependence and impuls-
vity (McClernon and Kollins, 2008). Therefore, we  calculated the
orrelations between the FTND and the primary outcome measures
performance on the separate neurocognitive tasks). In our sam-
le, FTND scores did not correlate with any of the primary outcome
easures (all correlations lower than r = 0.32; P ≥ 0.13).
. Discussion
ADHD patients with cocaine dependence showed signiﬁ-
antly higher levels of both motor and cognitive impulsivity
han ADHD patients without cocaine dependence as well as
ealthy controls. However, no performance differences were found
n other cognitive functions (interference control, attentional
et-shifting, time reproduction and working memory) between
DHD patients with and without cocaine dependence, indi-
ating that the observed differences in impulsivity cannot be
ttributed to a general deﬁcit in executive functions in ADHD
atients with cocaine dependence. Moreover, only one of the
elf-reported impulsivity subscales (BIS attention) was  signiﬁ-
antly higher in ADHD patients with cocaine dependence and
o differences or correlations with ADHD symptom scores (ASRS
cores) were observed compared to ADHD patients without cocaine
ependence.
Previous research has shown differences between adult ADHD
opulations and healthy controls in a broad range of additional neu-
ocognitive functions in both executive and motivational/reward
ircuitries (Bramham et al., 2012; Cummins et al., 2011; Finke
t al., 2011; Ibán˜ez et al., 2011; Marx et al., 2011; Valko et al.,
010; Wilbertz et al., 2012), providing evidence for the dual-
athway model in ADHD (Sonuga-Barke, 2003). However, here,
e observed no statistically signiﬁcant differences on neurocog-
itive measures between healthy controls and ADHD patients
without cocaine dependence). This discrepancy with previous
esults might be due to the fact that we only included non-
edicated adult ADHD patients that were diagnosed in adulthood,
robably representing an ADHD population with fewer ADHD
ymptoms compared to adult ADHD patients diagnosed during
hildhood with persisting ADHD symptoms into adulthood and
eceiving medication to treat their ADHD symptoms. It should
lso be noted that our samples were relatively small and that
ubtle differences in performance could not be detected. The
atter also implies that the observed differences in impulsivity
etween ADHD patients with and without cocaine depend-
nce represent very robust and large effects, with effect sizes
Cohen’s d) of 1.03 and 0.89 for motor and cognitive impulsivity,
espectively.
These robust differences in two separate domains of impulsive
ehavior (response disinhibition as a marker for dysfunction in
xecutive circuitry and delayed discounting as a marker for alter-
tions in motivational/reward circuitry) between ADHD patients
ith and without cocaine dependence support the dual-pathway
odel of ADHD in ADHD patients with cocaine dependence.
hile both motor and cognitive impulse control depend on
ntact functioning of the frontal lobes (Watanabe et al., 2002;
instanley et al., 2004), different parts of the frontal lobes are
ssumed to be related to the various subtypes of inhibition (RubiaDependence 129 (2013) 18– 24
et  al., 2001). In a study by Malloy-Diniz et al. in ADHD patients,
deﬁcits were found on distinct components of impulsivity (motor,
cognitive and attentional) but these measures were not signiﬁ-
cantly correlated (Malloy-Diniz et al., 2007), providing evidence
for separate aspects of impulsive behaviors in ADHD. In contrast,
in our study, we  found a strong correlation between measures
of motor and cognitive impulsivity in ADHD patients, here sug-
gesting the presence of an overall impairment of frontal lobe
function. This correlation between motor and cognitive impuls-
ivity was even stronger in our sample of ADHD patients with
cocaine dependence. Consistent with the literature (e.g., Broos
et al., 2012), we  did not observe this correlation in HCs, and one
may speculate that, while HCs activate speciﬁc parts of frontal
lobes necessary for adequate inhibition of motor or decision
making, ADHD patients recruit additional perhaps overlapping
frontal lobe (resulting from independent executive and moti-
vational/reward) circuitries in an attempt to achieve adequate
inhibition. Whether such overlapping inhibitory networks are
involved in various impulse control processes in ADHD patients
with and without SUD should be investigated in imaging stud-
ies during separate response inhibition and delay discounting
tasks.
Our ﬁndings of increased motor and cognitive impulsivity
in ADHD patients with cocaine dependence are in accordance
with previous studies in chronic cocaine using individuals. For
example, Fillmore and Rush (2002) found increased motor impuls-
ivity (decreased response inhibition) in chronic cocaine users
compared to matched healthy controls. However, measures of
SSRT were much higher in controls and in chronic cocaine
users in the Fillmore et al. study compared to our study, mean
SSRT in control participants being twice as high as in our
healthy controls. This discrepancy may  reﬂect methodological
aspects (task paradigm and/or study sample), but also demon-
strates that comparing results from studies in cocaine users and
cocaine dependent ADHD patients is not straightforward. Conse-
quently, future studies should aim to compare impulsive behaviors
between ADHD patients with and without cocaine dependence,
non-ADHD cocaine dependent patients and HCs within a single
design.
Our study has both strengths and limitations. A major strength
of our study is that our sample was diagnosed using validated tests
by trained professionals and that we  included only non-medicated
male patients and male controls that were matched for age and
IQ. Also, patients were extensively screened to exclude the occur-
rence of other comorbid disorders to reduce possible confounding
effects. However, ADHD patients with cocaine dependence were
more heavy smokers (higher FTND scores), whereas the ADHD
group without cocaine dependence included more ADHD patients
with a predominantly inattentive subtype (47% compared to 27%).
However, the observed differences in behavioral impulsivity in
ADHD patients with and without cocaine dependence were very
robust and FTND scores were not correlated with task performance,
and therefore we consider it unlikely that these ﬁndings are driven
by the differences in smoking behavior. Moreover, ASRS scores
did not differ between ADHD patients with and without cocaine
dependence. However, replication of our ﬁndings in larger samples
is needed.
In conclusion, this is the ﬁrst study showing that ADHD patients
with comorbid cocaine dependence are more impulsive than
age- and IQ-matched ADHD patients without cocaine depend-
ence. With regard to the neuropsychological theories of ADHD,
our results indicate the presence of increased impulsivity in ADHD
patients with comorbid cocaine dependence related to dysfunc-
tions in both the executive circuitry (response inhibition) and the
reward/motivational circuitry (delayed discounting). These ﬁnd-
ings are important when considering treatment of ADHD patients
lcohol 
w
e
p
R
n
c
t
C
v
s
t
w
C
A
o
L
p
R
B
B
B
B
C
C
C
C
F
F
H
H
HC.L. Crunelle et al. / Drug and A
ith comorbid SUD, and special attention should be paid to psycho-
ducation and the treatment of impulsive problems in these
atients.
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